Cancer clinical trial accrual: We have a problem

Journal of Cancer Education

Volumn 26, Issue 3, 2011, Pages 403-404

  Padberg, Rose Mary ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL (TOPIC); EDITORIAL; HUMAN; NEOPLASM; PATIENT SELECTION; STATISTICS;

CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASMS; PATIENT SELECTION;

EID: 80855132926     PISSN: 08858195     EISSN: 15430154     Source Type: Journal    
DOI: 10.1007/s13187-011-0224-0     Document Type: Editorial

References (5)

1. Comis RL, Miller JD (2005) Cancer clinical trials awareness and attitudes in cancer survivors. Coalition of Cancer Cooperative Groups 2005 [cited 2010 Aug 26]. Available from: Http://www.cancertrialshelp.org/lcare-content/ icMainContent.asps?intAppMode=19
2. Murthy VH, Krumholtz HM, Gross CP (2004) Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA 291(22):2720-2726 (Pubitemid 38725421)
3. Dilts DM, Sandler AB (2006) Invisible barriers to clinical trials: The impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials. J Clin Oncol 24(28):4545-4552 (Pubitemid 46630949)
4. Cheng S, Dietrich M, Finnigan S, Sandler A, Crites J, Ferranti L, et al. (2009) A sense of urgency: Evaluating the link between clinical trial development time and accrual performance of CTEPsponsored studies. J Clin Oncol 27:(18s)
5. Institute of Medicine Committee on Cancer Clinical Trials and the NCI Cooperative Group Program (2010) Nass SJ, Moses HI, Mendelsohn J (eds) A national cancer clinical trials system for the 21st century: Reinvigorating the NCI Cooperative Group Program. National Academics Press Washington DC